Trial Details
TERMINATEDBasic Information
| Clinical ID | c3827 |
|---|---|
| Identifier | NCT01471379 |
| Trial Title | Milnacipran (Savella) in Irritable Bowel Syndrome (IBS) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Irritable Bowel Syndrome |
| Interventions | DRUG: Milnacipran|DRUG: Milnacipran|DRUG: Milnacipran|DRUG: Placebo |
Participant Information
| Sponsor | Spencer Dorn, MD, MPH |
|---|---|
| City | Chapel Hill |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | FEMALE |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2012-04 |
|---|---|
| Primary Completion Date | 2013-02 |
| Completion Date | 2013-02 |